AXL phosphosite mapping links FAK1 and YAP1 signaling to erlotinib resistance in EGFR-mutant lung cancer
Cell Reports · 2026-07 · 45 (7) · 117717
DOI: 10.1016/j.celrep.2026.117717 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Reports, 2026-07. Verfasst von Marc Creixell und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bioengineering, University of California, Los Angeles, Los Angeles, CA 90095, USA; Jonsson Comprehensive Cancer Center, University of C…. Hauptthemen laut MEDLINE: Drug Resistance, Neoplasm, Erlotinib Hydrochloride, Lung Neoplasms, Proto-Oncogene Proteins. Die Arbeit nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, National Institutes of Health Office of Extramural Research, The Mark Foundation for Cancer Research.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Bioengineering, University of California, Los Angeles, Los Angeles, CA 90095, USA; Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, CA 90095, USA.
- Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; Cen…
- Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge CB2 2RE, UK.
- Department of Bioengineering, University of California, Los Angeles, Los Angeles, CA 90095, USA; Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, CA 90095, USA. Electronic address…
Förderung
- NCI NIH HHS
- National Institutes of Health Office of Extramural Research
- The Mark Foundation for Cancer Research
Zitieren
APA
Creixell, M., Taylor, S. D., Gerritsen, J., Jiang, M., Bae, S. Y., Augustin, T., Loui, M., Boixo, C., Minamino, S., Gong, V., Creixell, P., White, F. M., & Meyer, A. S. (2026). AXL phosphosite mapping links FAK1 and YAP1 signaling to erlotinib resistance in EGFR-mutant lung cancer. Cell Reports, 45(7), 117717. https://doi.org/10.1016/j.celrep.2026.117717
Vancouver
Creixell M, Taylor SD, Gerritsen J, Jiang M, Bae SY, Augustin T, et al. AXL phosphosite mapping links FAK1 and YAP1 signaling to erlotinib resistance in EGFR-mutant lung cancer. Cell Reports. 2026;45(7):117717. doi:10.1016/j.celrep.2026.117717
BibTeX
@article{Creixell2026,
author = {Creixell, Marc and Taylor, Scott D and Gerritsen, Jacqueline and Jiang, Mingxuan and Bae, Song Yi and Augustin, Teresa and Loui, Michelle and Boixo, Carmen and Minamino, Saki and Gong, Victoria and Creixell, Pau and White, Forest M and Meyer, Aaron S},
title = {AXL phosphosite mapping links FAK1 and YAP1 signaling to erlotinib resistance in EGFR-mutant lung cancer},
journal = {Cell Reports},
year = {2026},
volume = {45},
number = {7},
pages = {117717},
doi = {10.1016/j.celrep.2026.117717}
}
EUVIMED